US EditionDrugmaker files emergency appeal to restore access to mail-order abortion pill mifepristone
Danco says the ruling would disrupt care for millions of patients, as telehealth now accounts for about 25% of U.S. abortion prescriptions.
- On Saturday, Danco Laboratories filed an emergency request with the Supreme Court to immediately pause a lower court ruling that blocks mail-order access to mifepristone. The filing seeks to restore nationwide telehealth distribution of the abortion drug.
- The Fifth Circuit Court of Appeals ruled Friday that Louisiana was likely to prevail in its challenge, essentially reimposing an FDA requirement for in-person medical exams. The panel argued the 2023 rule change lacked scientific basis.
- Danco argued the ruling "injects immediate confusion and upheaval into highly time-sensitive medical decisions," forcing providers and pharmacies to guess what is allowed. The company warned the nationwide ban threatens Mifeprex, its only revenue source.
- Medication abortion accounts for nearly two-thirds of U.S. abortions, and the ruling significantly curbs access in states that have banned the procedure. Nearly half of all states have restricted abortion since the Supreme Court's 2022 decision.
- Drugmakers could ask the full Fifth Circuit to reconsider or appeal to the 6-3 conservative-majority Supreme Court. The Trump administration is reviewing mifepristone safety, a process expected to extend beyond the midterm elections.
106 Articles
106 Articles
The Supreme Court is being asked to restore access to an abortion pill by mail. Here’s what to know - Boston News, Weather, Sports
Two makers of the widely used abortion pill mifepristone asked the Supreme Court on Saturday to block an appellate court ruling that cut off mail-order access to the drug just a day earlier, in what was the biggest jolt to abortion policy in the U.S. since the overturning of Roe v. Wade. Danco Laboratories asked the high court for an emergency pause on the 5th U.S. Circuit Court of Appeals decision, saying the appellate ruling “injects immediate…
One of the two manufacturers of the abortion pill mifepriston initiated expedited proceedings at the U.S. Supreme Court on Saturday. The proceedings come one day after a federal court of appeals ruled that the abortion pill may no longer be sent by mail throughout the U.S. for the time being.
Volkskrant
trouw.nl
Abortion Pill Maker Asks SCOTUS to Allow Mail-Order Deliveries of Mifepristone
The makers of mifepristone, which is part of a two-drug regimen often called “the abortion pill,” asked the Supreme Court on May 2 to allow the prescription medication to be sent in the mail after a lower court blocked it. The application for an emergency stay was filed one day after the U.S. Court of Appeals for the Fifth Circuit paused a Food and Drug Administration rule that allowed the abortion drug to be mailed. “Never before has a federal …
Coverage Details
Bias Distribution
- 42% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
